Janet Tan, CEO of A-Sonic Aerospace, raised her stake in the company after it had received approval from Singapore Exchange to exit the Watch-list on June 30. The most recent market purchase for Tan was on Aug 19. She had acquired 23,900 shares for a total of $19,871.42 or 83.144 cents each. The acquisition raises her stake to 42,9 million shares, equivalent to 60.31%, up from 60.28% previously. Earlier on Aug 11, 12 and 16; she had acquired 19,000 shares for 77.84 cents each, 26,000 shares for 78.875 cents each and 13,000 shares for 79.785 cents each respectively.
Irene Tay, one of A-Sonic’s executive directors, also raised her stake in the company. On Aug 11, Tay acquired 8,000 shares from the open market for 78.563 cents each. This brings her total stake to nearly 1.04 million shares, equivalent to 1.46%. On Aug 10, A-Sonic announced earnings for 1HFY2022 ended June was $4.06 million, up 25.3% from $3.24 million a year ago. Revenue in the same period rose 15.3% to $222 million. The company enjoyed recovery from its two key businesses, aerospace and logistics.
From metals to meta
Bernard Ng, executive chairman and group CEO of Meta Health, started buying shares of the company from the open market. On Aug 15, he acquired two million shares for $59,036 or 2.95 cents each. On Aug 17, he bought another two million shares for $61,100 or 3.06 cents each. His total of four million shares is equivalent to 0.74% of the company’s share base.
Meta Health was previously known as Metal Component Engineering, before it expanded into the healthcare business with the acquisition of various related entities. This was funded by new shareholders, one of whom was Yong Yean Chau, CEO of the manager of ParkwayLife REIT.
On Aug 12, Meta Health reported a loss of $2.8 million for 1HFY2022 ended June, versus earnings of $11,000 a year ago. Excluding oneoff expenses related to the shutdown of one of its factories in Thailand, stock-based compensation and professional fees incurred for the investments in the new healthcare business, Meta Health recorded an adjusted net loss of $1.5 million for 1HFY2022. Revenue was down 7.3% y-o-y to $18.7 million, as its old metals parts business generated lower sales.
See also: Stamford Land’s executive chairman ups stake to 46.059%
On the other hand, the new healthcare business started contributing to the top line meaningfully, with $2.3 million reported for 1HFY2022.
Lo and behold
Wee Teng Wen, a non-independent, non-executive director of United Hampshire US REIT, raised his stake in the REIT by buying from the open market. On Aug 16 and 17, he acquired 660,000 units at 63 US cents each and another 726,000 units at 63.15 US cents each respectively. This brings his total stake to 1.585 million units. He first bought into the company on July 8, when he acquired 193,000 shares for 62 US cents each.
See also: Raffles Medical Group chairman ups stake to 55.592%
Wee is the son of Wee Ee Cheong, CEO of United Overseas Bank, and better known as the managing director of The Lo and Behold Group, which runs various F&B outlets. One of the sponsors of United Hampshire is UOB Global Capital LLC, a global asset management subsidiary of the bank.
On Aug 12, United Hampshire announced a DPU of 2.91 US cents ($0.0406) for 1HFY2022 ended June, down 4.6% y-o-y. Net property income for the period in review was up 10.6% y-o-y from US$20.5 million to US$22.7 million.
Separately, Wee Ee Cheong, has been buying shares of the bank from the market recently too, spending some $2 million over three trading days. On Aug 19, Wee acquired 25,000 shares for $26.80 each. On Aug 22, he bought another 25,000 shares, paying $26.7227 each. On Aug 16, he acquired 50,000 shares for $26.95. He now holds a direct stake of around 3.18 million shares, equivalent to 0.19% of the company. In addition, he has a deemed interest in another 173.7 million shares. Altogether, this gives him a total interest of nearly 176.89 million shares, equivalent to 10.56%.
